← back to search

Lan Zhang

Ministry of Education · NZ
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Autophagy in Disease and Therapy, Cancer-related molecular mechanisms research, and RNA modifications and cancer.
h-index
64
citations
18,322
works
808
NIH funding
primary concept
email

Recent publications

Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases
Acta Pharmaceutica Sinica B 2026cited by 1position: contributordoi
Targeting mitochondria in triple-negative breast cancer: Emerging therapeutic and drug development strategies.
2026cited by 0position: contributordoi
Targeting ATR in Cancer therapy: A drug discovery perspective.
2026cited by 0position: contributordoi
Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer.
2026cited by 0position: contributordoi
Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria
Journal for ImmunoTherapy of Cancer 2025cited by 16position: middledoi
Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery.
2025cited by 6position: contributordoi
Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies.
2025cited by 4position: contributordoi
Discovery of a novel Fam20C inhibitor for treatment of triple-negative breast cancer.
2025cited by 3position: contributordoi
Repurposing antitumor drugs for the treatment of non-oncological diseases: Mechanistic insights, clinical evidence, and future perspectives.
2025cited by 2position: contributordoi
Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy.
2025cited by 2position: contributordoi
Dl‐3‐n‐Butylphthalide Promotes Cortical Angiogenesis via Akt/GSK‐3β Signaling in Ischemic Stroke Mice
CNS Neuroscience & Therapeutics 2025cited by 1position: firstdoi
Eriocalyxin B induces ferroptosis through SIRT3 inhibition in triple-negative breast cancer.
2025cited by 1position: contributordoi
Unraveling the mysterious veil of ULK1: From non-canonical functions to therapeutic applications.
2025cited by 1position: contributordoi
Aluminum Induced Higher Neurotoxicity than Nano-Alumina During Early Development in Zebrafish, Exacerbated by Trem2 Knockdown
Biological Trace Element Research 2025cited by 1position: middledoi
Lipoic acid remodels neurovascular units through the AMPK/NLRP3 signaling pathway after cerebral infarction
Folia Neuropathologica 2025cited by 0position: middledoi
Identification of immunosuppressive CD4<sup>+</sup> T-cell subtype and construction of prognostic model for hepatocellular carcinoma.
2025cited by 0position: contributordoi
Computational identification of potential UNC-51-like kinase 1 inhibitors by an integrated structure-based and molecular dynamics-guided approach.
2025cited by 0position: contributordoi
Corrigendum to "Discovery of a novel Fam20C inhibitor for treatment of triple-negative breast cancer" [Int. J. Biol. Macromol. 286(2024) 138398].
2025cited by 0position: contributordoi
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
EClinicalMedicine 2024cited by 136position: middledoi
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer.
2024cited by 31position: contributordoi
Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies.
2024cited by 24position: contributordoi
Detection of circulating plasma cells in peripheral blood using deep learning‐based morphological analysis
Cancer 2024cited by 17position: middledoi
Avicularin inhibits ferroptosis and improves cognitive impairments in Alzheimer's disease by modulating the NOX4/Nrf2 axis.
2024cited by 17position: contributordoi
ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions.
2024cited by 11position: contributordoi
The substitution sites of hydroxyl and galloyl groups determine the inhibitory activity of human pancreatic α-amylase in twelve tea polyphenol monomers
International Journal of Biological Macromolecules 2024cited by 10position: firstdoi
Unraveling the multifaceted role of SIRT7 and its therapeutic potential in human diseases.
2024cited by 8position: contributordoi
Identification of activating transcription factor 6 (ATF6) as a novel prognostic biomarker and potential target in oral squamous cell carcinoma.
2024cited by 8position: contributordoi
Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs.
2024cited by 8position: contributordoi
Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy.
2024cited by 6position: contributordoi
Combination treatment with ferroptosis and autophagy inducers significantly inhibit the proliferation and migration of oral squamous cell carcinoma.
2024cited by 4position: contributordoi

Grants

CAREER: Towards Semantic-Centric Wireless Foundations for Swarm AI
NSF2542152$551,5852026–2031PIRePORTER
CRII: SaTC: Adversarial Malware Generation: A Universal Evasion Framework Targeting Neural Network-based Malware Detectors
NSF2451231$174,1032025–2027PIRePORTER
Collaborative Research: Statistical Inference for High Dimensional and High Frequency Data: Contiguity, Matrix Decompositions, Uncertainty Quantification
NSF2413953$155,3722024–2027PIRePORTER
CRII: CNS: IoT-aware Federated On-Device Intelligence
NSF2418308$122,7052024–2025PIRePORTER
CRII: CNS: IoT-aware Federated On-Device Intelligence
NSF2153381$174,9672022–2024PIRePORTER
Collaborative Research: Statistical Inference for High Dimensional and High Frequency Data
NSF2015530$149,9922020–2024PIRePORTER
Collaborative Research: Statistical Inference for High-Frequency Data
NSF1713118$140,5622017–2021PIRePORTER
Collaborative Research: Better efficiency, better forecasting, better accuracy: A new light on the dependence structure in high frequency data
NSF1407820$123,8512014–2018PIRePORTER

Frequent collaborators

· 23 papers (2022–2026)Zhenggang Ren · Ministry of Education of the People's Republic of China13 papers (2012–2025)Xiaoying Xie · Fudan University9 papers (2012–2019)Boheng Zhang · Fudan University7 papers (2012–2017)Yanhong Wang · Fudan University6 papers (2012–2016)Xiangjian Zhang · Hebei Medical University6 papers (2012–2025)Liang Ouyang · Sichuan University6 papers (2020–2021)Rongxin Chen · Sun Yat-sen University6 papers (2012–2019)Tong‐Chun Xue · Fudan University5 papers (2013–2016)Yanzhao Wu · Hebei Medical University4 papers (2019–2023)Ningling Ge · Fudan University4 papers (2012–2015)Xiaocheng Gao · Shanxi Medical University4 papers (2020–2025)Sheng‐Long Ye · Chinese Academy of Sciences4 papers (2012–2015)Qinli Zhang · Xuzhou Medical College4 papers (2020–2025)Xin Yin · Fudan University4 papers (2013–2019)Qi Wang · Hebei Medical University3 papers (2016–2020)Lina Wang · Hubei University of Science and Technology3 papers (2012–2019)Ping Shi · Qujiang People's Hospital3 papers (2022–2023)Lixia Chen · Harbin University of Science and Technology3 papers (2020–2021)Lin Li · Nanchang University3 papers (2016–2021)